Latest Spago Nanomedical News & Updates

See the latest news and media coverage for Spago Nanomedical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Spago Nanomedical

Clinical-stage nanomedicines company

spagonanomedical.se
Headquarters
Lund, Sweden
Founded year
2007
Company type
Public company
Number of employees
15–50

Latest news about Spago Nanomedical

Company announcements

  • Spago Nanomedical

    Spago Nanomedical continues recruitment in Tumorad-01 study

    The DMC recommends adding two patients at current dose after reviewing safety data from 14 patients, confirming acceptable profile. Visible tumor uptake observed.

  • Spago Nanomedical

    Spago Nanomedical appoints Torsten Malmström as Director CMC & Supply

    He joins the management team to support Tumorad's next clinical phase with extensive CMC experience. The appointment strengthens capabilities for development and commercialization.

  • Spago Nanomedical

    Spago Nanomedical publishes year-end report for 2025

    Net sales amounted to KSEK 437 with a loss of KSEK 26,554. DMC recommended dose escalation in Tumorad-01. Rights issue raised MSEK 24.4.

  • Spago Nanomedical

    Spago Nanomedical announces oversubscribed rights issue

    The issue is subscribed to 105.7%, raising SEK 25 million before costs. CEO expresses confidence in ongoing development of Tumorad® and 177Lu-SN201.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Spago Nanomedical

Track Spago Nanomedical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.